PET/CT scan test for neuroendocrine tumors with a special tracer
Part of Cancer clinical trials.
This study uses a PET/CT scan with a small amount of radioactive tracer to see how neuroendocrine tumors are behaving in adults. It may help doctors better detect and evaluate these tumors, especially when symptoms suggest a carcinoid-type hormone problem.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older.
- If you can become pregnant, you must not be within the last 10 days of your last menstrual period and you will need a negative pregnancy test.
- Be able and willing to follow study instructions and attend required visits.
- Have symptoms suggestive of a neuroendocrine tumor or carcinoid-type hormone symptoms, or have a biopsy-proven neuroendocrine tumor.
- If you are pregnant or currently nursing, you cannot join.
- Do not have had surgery in the area being scanned within the last 2 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of PET/CT scans to see which one is better at finding and staging neuroendocrine tumors. If you qualify, you will get both scans, which may help your doctor plan your treatment more accurately.
This trial tests a new PET scan tracer to find neuroendocrine tumors in the body. It may help doctors see where the tumors are and plan better treatment.
This trial tests a special PET scan to better evaluate gastroenteropancreatic neuroendocrine tumors (GEP-NETs). It may help your doctor see where the tumors are in your body.
This study tests an imaging scan using a special tracer (68Ga-HA-DOTATATE) to look for tumors that have somatostatin receptors. It may help doctors better locate suspected tumor sites so treatment planning can be more accurate.
This trial tests a new type of PET scan using a radioactive tracer called 61Cu-NODAGA-LM3 to detect neuroendocrine tumors (NETs). The goal is to see if it works as well as or better than the standard scan. If you have a NET and need a scan for staging or treatment planning, you might be able to join.
This study looks at how a PET/CT scan (called gallium-68 DOTATOC) can also check your heart health while scanning for a neuroendocrine tumor. It aims to see if the routine scan can give extra information about your heart function without any extra visits or radiation.
Hear when a new Neuroendocrine Tumors, NET trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.